Welcome to CDC Stacks | Population-Level Effect of Cholera Vaccine on Displaced Populations, South Sudan, 2014 - 39683 | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Population-Level Effect of Cholera Vaccine on Displaced Populations, South Sudan, 2014
Filetype[PDF - 1.55 MB]


Details:
No Related Documents.
You May Also Like:
  1. Risk Factors for Sustained Cholera Transmission, Juba County, South Sudan, 2014
    Personal Author:
    Ujjiga, Thomas T.A.; Wamala, Joseph F.; Mogga, Juma J.H.; Othwonh, Thabo O.; Mutonga, David; Kone-Coulibaly, Asta; Ali, Masood; Mpairwe, Allan M.; Abdinasir, Abubaker; Abdi, Mohamed A.; Yoti, Zabulon; Olushayo, Olu; Nyimol, Pinyi; Lul, Riek; Lako, Richard L.; Rumunu, John;
    Published:
    Oct 2015
    Source:
    Emerg Infect Dis. 21(10):1849-1852.
    Description:
    We conducted a case-control study to identify risk factors for the 2014 cholera outbreak in Juba County, South Sudan. Illness was associated with traveling or eating away from home; treating drinking water and receiving oral cholera vaccination were ...
    File Type:
    Filetype[PDF - 391.96 KB]
  2. Modeling the Effect of Water, Sanitation, and Hygiene and Oral Cholera Vaccine Implementation in Haiti
    Personal Author:
    Chun-Hai Fung, Isaac; Fitter, David L.; Borse, Rebekah H.; Meltzer, Martin I.; Tappero, Jordan W.;
    Published:
    Oct 2013
    Source:
    Am J Trop Med Hyg. 2013; 89(4):633-640.
    Description:
    In 2010, toxigenic Vibrio cholerae was newly introduced to Haiti. Because resources are limited, decision-makers need to understand the effect of different preventive interventions. We built a static model to estimate the potential number of cholera ...
    File Type:
    Filetype[PDF - 442.98 KB]
  3. Population–level effectiveness of PMTCT Option A on early mother–to–child (MTCT) transmission of HIV in South Africa: implications for eliminating MTCT
    Personal Author:
    Goga, Ameena E; Dinh, Thu–Ha; Jackson, Debra J; Lombard, Carl J; Puren, Adrian; Sherman, Gayle; Ramokolo, Vundli; Woldesenbet, Selamawit; Doherty, Tanya; Noveve, Nobuntu; Magasana, Vuyolwethu; Singh, Yagespari; Ramraj, Trisha; Bhardwaj, Sanjana; Pillay, Yogan;
    Corporate Author:
    for the South Africa PMTCT Evaluation (SAPMCTE) Team
    Published:
    Dec 2016
    Source:
    J Glob Health. 2016; 6(2).
    Description:
    Background : Eliminating mother–to–child transmission of HIV (EMTCT), defined as ≤50 infant HIV infections per 100 000 live births, is a global priority. Since 2011 policies to prevent mother–to–child transmission of HIV (PMTCT) shifted f...
    File Type:
    Filetype[PDF - 1.88 MB]
  4. Longitudinal Detection and Persistence of Minority Drug-Resistant Populations and Their Effect on Salvage Therapy
    Personal Author:
    Nishizawa, Masako; Matsuda, Masakazu; Hattori, Junko; Shiino, Teiichiro; Matano, Tetsuro; Heneine, Walid; Johnson, Jeffrey A.; Sugiura, Wataru;
    Published:
    Sep 11 2015
    Source:
    PLoS One. 10(9).
    Description:
    Background : Drug-resistant HIV are more prevalent and persist longer than previously demonstrated by bulk sequencing due to the ability to detect low-frequency variants. To clarify a clinical benefit to monitoring minority-level drug resistance popu...
    File Type:
    Filetype[PDF - 1.26 MB]
  5. Systematic Review of the Effect of Pneumococcal Conjugate Vaccine Dosing Schedules on Vaccine-type Nasopharyngeal Carriage
    Personal Author:
    Fleming-Dutra, Katherine E.; Conklin, Laura; Loo, Jennifer D.; Knoll, Maria Deloria; Park, Daniel E.; Kirk, Jennifer; Goldblatt, David; Whitney, Cynthia G.; O’Brien, Katherine L.;
    Published:
    Jan 2014
    Source:
    Pediatr Infect Dis J. 2014; 33(Suppl 2 Optimum Dosing of Pneumococcal Conjugate Vaccine For Infants 0 A Landscape Analysis of Evidence Supportin g Different Schedules):S152-S160.
    Description:
    Background: : Pneumococcal conjugate vaccines (PCV) reduce nasopharyngeal carriage of vaccine type (VT) pneumococci, an important driver of vaccine programs’ overall benefits. The dosing schedule that best reduces carriage is unclear. : Methods: : ...
    File Type:
    Filetype[PDF - 908.77 KB]